Literature DB >> 7576478

Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases.

J C Peng1, T S Sheen, M M Hsu.   

Abstract

OBJECTIVES: To evaluate the incidence rate of nasopharyngeal carcinoma with dermatomyositis, the influence of dermatomyositis on clinical course, and complications and survival of patients with nasopharyngeal carcinoma after radiotherapy.
DESIGN: A retrospective study of 12 patients with nasopharyngeal carcinoma associated with dermatomyositis, with a maximum follow-up of 228 months.
SETTING: Academic tertiary referral center. PATIENTS: There were 6441 new patients with nasopharyngeal carcinoma who were seen at the National Taiwan University Hospital, Taipei, during the period from 1970 through 1993. Twelve patients were found to have dermatomyositis. MAIN OUTCOME MEASURE: Clinical manifestations of nasopharyngeal carcinoma with dermatomyositis.
RESULTS: Twenty-seven (26%) of 104 patients with dermatomyositis had an associated malignancy. Twelve of these patients were diagnosed as having nasopharyngeal carcinoma. The typical skin manifestation of dermatomyositis was found in all 12 patients. Myopathy occurred in 10 patients. Three patients died of recurrence of nasopharyngeal carcinoma, one died of a second malignancy, one died of upper gastrointestinal bleeding, and one became unavailable for follow-up. The other six patients have had disease-free survival, with a mean follow-up period of 100.5 months (range, 5 to 228 months). The 1-year survival rate was 83.8%, and the 5-year survival rate was 69.4%.
CONCLUSIONS: In Taiwan, dermatomyositis is associated with an increased incidence rate of nasopharyngeal carcinoma. A search for nasopharyngeal carcinoma in patients with dermatomyositis should be performed in areas prevalent for nasopharyngeal carcinoma. If present, nasopharyngeal carcinoma can precede, occur concurrently with, or follow the diagnosis of dermatomyositis. Treatment of nasopharyngeal carcinoma may affect myositic or cutaneous disease. The prognosis and survival rates of nasopharyngeal carcinoma remained unaffected by dermatomyositis. No complications were noted owing to the radiotherapy used to treat dermatomyositis.

Entities:  

Mesh:

Year:  1995        PMID: 7576478     DOI: 10.1001/archotol.1995.01890110072013

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  14 in total

1.  Dermatomyositis and duodenal carcinoid.

Authors:  Vikas Agarwal; Atul Sachdev; Rajeev Sharma; Rajpal Singh Punia
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

Review 2.  Paraneoplastic rheumatic syndromes.

Authors:  Csilla András; Zoltán Csiki; Andrea Ponyi; Arpád Illés; Katalin Dankó
Journal:  Rheumatol Int       Date:  2005-08-10       Impact factor: 2.631

3.  Nasopharyngeal carcinoma in dermatomyositis patients: A 10-year retrospective review in Hospital Selayang, Malaysia.

Authors:  J W Teoh; Razif M Yunus; Faridah Hassan; Norazmi Ghazali; Zainal A Z Abidin
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-15

4.  Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis.

Authors:  Hua Cao; Tanvi N Parikh; Jie Zheng
Journal:  Clin Rheumatol       Date:  2009-03-18       Impact factor: 2.980

5.  Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan.

Authors:  Yi-Ju Chen; Chun-Ying Wu; Yu-Lin Huang; Chang-Bi Wang; Jui-Lung Shen; Yun-Ting Chang
Journal:  Arthritis Res Ther       Date:  2010-04-16       Impact factor: 5.156

6.  Clear cell ovarian carcinoma following polymyositis diagnosis: a case report and review of the literature.

Authors:  I Kalogiannidis; A Papanikolaou; I Xanthakis; A Makedos; N Prapas
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

7.  The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis.

Authors:  Vidya Limaye; Colin Luke; Graeme Tucker; Catherine Hill; Susan Lester; Peter Blumbergs; Peter Roberts-Thomson
Journal:  Rheumatol Int       Date:  2012-07-26       Impact factor: 2.631

8.  Polymyositis associated with non-secretory myeloma - a case report.

Authors:  S Vallabhajosyula; R Bekur; R Bhat; Nc Gnanadev; S Belurkar
Journal:  Australas Med J       Date:  2011-04-30

Review 9.  Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology.

Authors:  V Madan; H Chinoy; C E M Griffiths; R G Cooper
Journal:  Clin Exp Dermatol       Date:  2009-07       Impact factor: 3.470

10.  Clinical characteristics and outcomes of juvenile and adult dermatomyositis.

Authors:  Sang-Jun Na; Seung Min Kim; Il Nam Sunwoo; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.